Gilead Sciences (GILD) Change in Acquisitions & Divestments (2016 - 2025)
Gilead Sciences (GILD) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with -$459.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 76.32% year-over-year to -$459.0 million, compared with a TTM value of $55.0 million through Dec 2025, down 83.18%, and an annual FY2025 reading of $55.0 million, down 83.18% over the prior year.
- Change in Acquisitions & Divestments was -$459.0 million for Q4 2025 at Gilead Sciences, down from $499.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $1.9 billion in Q2 2024 and bottomed at -$1.9 billion in Q4 2024.
- Average Change in Acquisitions & Divestments over 5 years is $158.8 million, with a median of $266.0 million recorded in 2021.
- The sharpest move saw Change in Acquisitions & Divestments plummeted 466.07% in 2022, then soared 27785.71% in 2024.
- Year by year, Change in Acquisitions & Divestments stood at $224.0 million in 2021, then tumbled by 466.07% to -$820.0 million in 2022, then skyrocketed by 212.44% to $922.0 million in 2023, then plummeted by 310.2% to -$1.9 billion in 2024, then soared by 76.32% to -$459.0 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for GILD at -$459.0 million in Q4 2025, $499.0 million in Q3 2025, and $15.0 million in Q2 2025.